TokenPost topic
Iambic Therapeutics
4 TokenPost stories are tagged Iambic Therapeutics. The newest appear first.
Latest Iambic Therapeutics stories
- Iambic Therapeutics Posts 142.6% Q3 Collaboration Revenue Growth
Collaboration revenue reached $11.4 million, beating estimates by $3.11 million, while GAAP earnings per share missed by $7.75.
· Business
- Iambic Shares Close 18% Above IPO Price After Pricing $150 Million IPO
The $18.91 close implies a market value of about $896 million using Iambic’s estimated 47.4 million post-offering shares.
· Business
- Nvidia-Backed Iambic Therapeutics Prices IPO at $16 a Share
The AI drug developer is offering about 9.38 million shares and expects to begin trading on Nasdaq on Oct. 15 under ticker IAM.
· Business
- Iambic Therapeutics Plans Nasdaq IPO Above $800 Million Valuation
The Nvidia- and AbbVie-backed life sciences company plans to list under the ticker IAM and leverages artificial intelligence.
· Business